The Technical AnalystExchange: WSE Sector: Healthcare Industry: Pharmaceutical Retailers
NEUCA S.A. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% PLN941.00
America/New_York / 17 mai 2024 @ 11:02
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4 184.80 mill |
| EPS: | 32.46 |
| P/E: | 28.99 |
| Earnings Date: | May 16, 2024 |
| SharesOutstanding: | 4.45 mill |
| Avg Daily Volume: | 0.0009 mill |
| RATING 2024-05-17 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.36x |
| Company: PE 28.99 | sector: PE 21.29 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.58x |
| Company: PE 28.99 | industry: PE 18.31 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
PLN1 717.87 (82.56%) PLN776.87 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
PLN 924.47 - 957.53 ( +/- 1.76%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | PLN941.00 (0.00% ) |
| Volume | 0.0006 mill |
| Avg. Vol. | 0.0009 mill |
| % of Avg. Vol | 68.70 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NEU.WA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NEU.WA
NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, telemedicine, agency, financial, road cargo transport, accounting and bookkeeping, software, hospital, and information technology and computer related services; and health, property, and other personal insurance products. In addition, it operates outpatient care clinics and medical stores. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.